thus , glipizide offers a therapeutic advantage over chlorpropamide , but its effectiveness may be restricted not only by limitations set by the disease , but also by counter-regulatory mechanisms that develop during continuous exposure to sulfonylureas at high levels .
C0017642
glipizide
C0038766
sulfonylureas